This is from the FDA site:
FDA
Enforcement Report
The FDA Enforcement Report is published weekly by the Food and Drug Administration, U.S. Public Health Service, Department of Health and Human Services. It contains information on actions taken in connection with agency regulatory activities.
------------------------------------------------------------------------
ENFORCE
08/10/1994
PRODUCT Breast Transilluminator, Lintroscan> Model 200G used for the
detection of changes in the breast. Recall #Z-1184-4.
CODE Serial numbers: 080792-02, 082492-03, 082492-04, 01092-05,
01092-06, 01092-07.
MANUFACTURER <Lintronics Technologies, Inc., Tampa, Florida.
RECALLED BY Manufacturer, by telephone mid November 1993. Firm-
initiated recall complete.
DISTRIBUTION Illinois, Ohio, Georgia, Florida, Virginia.
QUANTITY 6 units.
REASON Product labeling fails to bear adequate directions for use.
FDA has concluded that transillumination for the examination
of the breast is not clinically effective for the diagnosis
or detection of breast cancer or other breast abnormalities
or conditions.
Obviously, I have no idea if Grable was behind Lintronics
|
